Literature DB >> 9736164

Clinical evaluation of the Mycobacteria Growth Indicator Tube (MGIT) compared with radiometric (Bactec) and solid media for isolation of Mycobacterium species.

W K Chew1, R M Lasaitis, F A Schio, G L Gilbert.   

Abstract

The aim of this study was to evaluate the clinical use of a new culture system for the isolation of mycobacteria. Routine clinical specimens were cultured in the Mycobacteria Growth Indicator Tube, the radiometric Bactec 460 TB system and on Lowenstein Jensen (LJ) medium to compare recovery rates and times for detection of mycobacteria and contamination rates. MGIT was tested for its ability to support the growth of a wide range of mycobacterial species. Acid-fast bacilli (AFB) were detected on direct smears of 76 of 603 clinical specimens and mycobacteria were isolated by at least one method from 109 specimens; 93% of these were detected in the MGIT, 95% in the Bactec 460 TB system and 87% on LJ medium. The MGIT, Bactec and LJ media detected 92%, 97% and 95%, respectively, of 61 M. tuberculosis isolates and 94%, 94% and 77% of the 48 isolates belonging to the M. avium complex (MAC). The mean detection times in MGIT, Bactec and LJ media for M. tuberculosis were 22, 14 and 27 days respectively, and for MAC were 14, 12, and 29 days, respectively. Growth of M. tuberculosis was detected in Bactec, within 4 weeks, in 93% of the 61 culture-positive specimens, compared with only 61% in MGIT and 66% on LJ. The number of MAC detected within 4 weeks was similar in Bactec and MGIT, but less in LJ medium. Differences in sensitivity and time to detection of growth between media were greater for specimens in which AFB were not detected on direct smear than those on which AFB were seen. Contamination rates were similar in the three systems (3-4%). MGIT supported the growth of all 28 Mycobacterium spp. inoculated. MGIT has significant safety advantages and is less labour intensive than other methods, but the time to detection of M. tuberculosis, especially in smear-negative specimens, was longer in MGIT than in Bactec.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736164     DOI: 10.1099/00222615-47-9-821

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  13 in total

Review 1.  Modern laboratory diagnosis of mycobacterial infections.

Authors:  S A Watterson; F A Drobniewski
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay.

Authors:  Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Vo Sy Kiet; Marcel Wolbers; Hoang Thi Thanh Hang; Jeremy Day; Nguyen Quang Hien; Nguyen Anh Tien; Pham Thuy An; Truong Thi Anh; Do Thi Tuong Oanh; Chau Luong Hoa; Nguyen Thi Minh Chau; Nguyen Ngoc Hai; Ngo Thanh Binh; Le Hong Ngoc; Doan Thanh Phuong; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Nguyen Thi Nho; Dai Viet Hoa; Phan Thi Hoang Anh; Nguyen Huy Dung; Jeremy Farrar; Maxine Caws
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

3.  Mycobacterium and Aerobic Actinomycete Culture: Are Two Medium Types and Extended Incubation Times Necessary?

Authors:  Patricia J Simner; Kelly A Doerr; Lory K Steinmetz; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

4.  Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy.

Authors:  Patrícia Quincó; Samira Bührer-Sékula; Walber Brandão; Rossiclea Monte; Silvia Leopoldina Souza; Valeria Saraceni; Moises Palaci; Reynaldo Dietze; Marcelo Cordeiro-Santos
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

5.  Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.

Authors:  F Ardito; B Posteraro; M Sanguinetti; S Zanetti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

6.  Two liquid medium systems, mycobacteria growth indicator tube and MB redox tube, for Mycobacterium tuberculosis isolation from sputum specimens.

Authors:  L Heifets; T Linder; T Sanchez; D Spencer; J Brennan
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

7.  A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture.

Authors:  Emmanuel Chigutsa; Kashyap Patel; Paolo Denti; Marianne Visser; Gary Maartens; Carl M J Kirkpatrick; Helen McIlleron; Mats O Karlsson
Journal:  Antimicrob Agents Chemother       Date:  2012-11-26       Impact factor: 5.191

8.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

9.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

10.  Laboratory diagnosis of tuberculous meningitis - is there a scope for further improvement?

Authors:  Rajeev Thakur; Renu Goyal; Smita Sarma
Journal:  J Lab Physicians       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.